BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
6.70
-0.02 (-0.22%)
Sep 5, 2025, 3:41 PM EDT
BioStem Technologies Revenue
BioStem Technologies had revenue of $49.30M in the quarter ending June 30, 2025, a decrease of -33.82%. This brings the company's revenue in the last twelve months to $307.26M, up 133.77% year-over-year. In the year 2024, BioStem Technologies had annual revenue of $301.83M with 1,708.93% growth.
Revenue (ttm)
307.26M
Revenue Growth
+133.77%
P/S Ratio
0.37
Revenue / Employee
9.31M
Employees
33
Market Cap
112.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 301.83M | 285.14M | 1,708.93% |
Dec 31, 2023 | 16.69M | 9.81M | 142.69% |
Dec 31, 2022 | 6.88M | 2.53M | 58.38% |
Dec 31, 2021 | 4.34M | 4.03M | 1,284.88% |
Dec 31, 2017 | 313.45K | -293.78K | -48.38% |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
BioStem Technologies News
- 6 hours ago - BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting - GlobeNewsWire
- 3 days ago - BioStem Technologies to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 15 days ago - BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer - GlobeNewsWire
- 21 days ago - BioStem Technologies, Inc. (BSEM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results - GlobeNewsWire
- 22 days ago - BioStem Technologies Appoints Brandon Poe as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes - GlobeNewsWire
- 2 months ago - BioStem Technologies to Present at the Advanced Wound Care Summit in Boston on July 15, 2025, at 2:00 PM ET - GlobeNewsWire